Skip to main content
. 2015 Dec 26;15:583. doi: 10.1186/s12879-015-1327-8

Table 1.

Patients characteristics and clinical outcome

Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6
Age (years) 64 23 39 29 18 18
Sex M M M F M M
CFTR mutation 1717-1GA/2789 + 5GA F508del/F508del F508del/F508del F508del/F508del F508del/R553X F508del/F508del
Date of first P. pulmonicola isolation 2000 March 2009 June 2009 October 2009 November 2009 December 2009
Associated pathogens mucoid P. aeruginosa mucoid P. aeruginosa mucoid P. aeruginosa mucoid P. aeruginosa S. aureus, mucoid. P. aeruginosa, A. xylosoxidans, A. fumigatus S. aureus, mucoid P. aeruginosa, A. fumigatus, G. argillacea
Best Forced Expiratory Volume in 1 second (FEV1) value per year 2009 25 45 33 43 47 61
2010 / 41 25 35 44 42
2011 / 40 20 / 42 41
2012 / 31 19 / / 59
2013 / 42 19 / / 60
Number of intravenous antibiotic courses per year 2009 8 2 6 10 7 8
2010 / 3 5 3 8 5
2011 / 1 4 / 7 6
2012 / 3 6 / / 1
2013 / 0 3 / / 0
Organ transplantation No No No (listed for heart and lung transplantation) Lung transplantation (March 2010) Lung and liver transplantation (April 2012) Lung transplantation (January 2012)
Clinical outcome Death (October 2009) from severe comorbidities Stable Decline in lung function Death (April 2010) from post transplantation bacteremia due to P. aeruginosa Death (May 2012) from severe multiple post transplantation organ failure Stable